Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Polyomavirus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT04705389
What this trial is testing

SerUM Markers in MERkel Cell Carcinoma Patients: a Longitudinal moniTorIng Study for optiMization of European Guidelines

Who this might be right for
Merkel Cell Carcinoma
University Hospital, Tours 35
Testing effectiveness (Phase 2)Study completedNCT02819843
What this trial is testing

T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors

Who this might be right for
MelanomaMerkel Cell CarcinomaOther Solid Tumors
Memorial Sloan Kettering Cancer Center 19
Testing effectiveness (Phase 2)Ended earlyNCT01620268
What this trial is testing

An Open-Label, Study to Treat Patients With Renal Allograft and Polyoma BK Viruria

Who this might be right for
ViruriaViremia
Changzheng-Cinkate 24
Post-approval studies (Phase 4)Study completedNCT00160966
What this trial is testing

Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant Nephropathy

Who this might be right for
Polyomavirus Infections
University of Giessen 108
Not applicableLooking for participantsNCT07732907
What this trial is testing

Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia

Who this might be right for
Multiple SclerosisProgressive Multifocal Leukoencephalopathy
Bristol-Myers Squibb 15
Not applicableEnded earlyNCT04106167
What this trial is testing

Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy

Who this might be right for
Advanced Solid TumorLymphomaGastric Cancer+15 more
Fate Therapeutics 20
Early research (Phase 1)Study completedNCT04242199
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+9 more
Incyte Corporation 182
Testing effectiveness (Phase 2)Ended earlyNCT00746941
What this trial is testing

Study to Explore the Effect of Mefloquine in Participants With Progressive Multifocal Leukoencephalopathy (PML)

Who this might be right for
Progressive Multifocal Leukoencephalopathy
Biogen 37
Testing effectiveness (Phase 2)Looking for participantsNCT05583708
What this trial is testing

Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer

Who this might be right for
Merkel Cell Carcinoma
Weill Medical College of Cornell University 18
Testing effectiveness (Phase 2)Ended earlyNCT04916002
What this trial is testing

A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer

Who this might be right for
Merkel Cell CarcinomaCutaneous Squamous Cell CarcinomaBasal Cell Carcinoma+3 more
Regeneron Pharmaceuticals 77
Testing effectiveness (Phase 2)Active Not RecruitingNCT06056895
What this trial is testing

Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel Cell Carcinoma

Who this might be right for
Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8Clinical Stage IV Merkel Cell Carcinoma AJCC v8Merkel Cell Carcinoma
University of Washington 12
Not applicableStudy completedNCT03532971
What this trial is testing

Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes

Who this might be right for
BK Virus Infection
Dana-Farber Cancer Institute 100
Not applicableLooking for participantsNCT05797415
What this trial is testing

Sentinel Lymph Node Biopsy in Ocular Surface and Adnexal Cancers

Who this might be right for
Ocular Sebaceous CarcinomaOcular Basal Cell CarcinomaOcular Surface Squamous Neoplasia+3 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 25
Early research (Phase 1)Active Not RecruitingNCT03212404
What this trial is testing

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell LungCarcinoma, Small Cell+10 more
Checkpoint Therapeutics, Inc. 272
Not applicableLooking for participantsNCT01730131
What this trial is testing

Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)

Who this might be right for
Progressive Multifocal Leukoencephalopathy
National Institute of Neurological Disorders and Stroke (NINDS) 700
Testing effectiveness (Phase 2)Study completedNCT00002395
What this trial is testing

Safety and Effectiveness of Topotecan HCl to Treat HIV-Infected Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy (PML)

Who this might be right for
HIV InfectionsLeukoencephalopathy, Progressive Multifocal
SmithKline Beecham 54
Testing effectiveness (Phase 2)Looking for participantsNCT07387198
What this trial is testing

Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab

Who this might be right for
Merkel Cell Carcinoma, Stage IMerkel Cell Carcinoma, Stage IINeoadjuvant Immunotherapy
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 135
Early research (Phase 1)Study completedNCT03000257
What this trial is testing

Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
AbbVie 182
Not applicableStudy completedNCT01981161
What this trial is testing

Difference in Efficacy of Natalizumab Versus Fingolimod for the Treatment of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University Hospital, Toulouse 307
Early research (Phase 1)Looking for participantsNCT05076760
What this trial is testing

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

Who this might be right for
Solid TumorAdvanced CancerMetastatic Cancer+7 more
Memgen, Inc. 40
Next Page